Painful Post-traumatic Trigeminal Neuropathy Improved with Seungmagalgeun-tang-gamibang and Acupuncture: A Case Report

Article information

J Korean Med. 2026;47(2):234-243
Publication date (electronic) : 2026 June 1
doi : https://doi.org/10.13048/jkm.26031
1Chief Korean Medicine Doctor, Doochung Korean Medicine Clinic
2Staff Korean Medicine Doctor, Doochung Korean Medicine Clinic
*Correspondence to: Do-Hwan Kim, 2F, 250, Gangnam-daero, Gangnam-gu, Seoul, Republic of Korea, Tel: +82-2-574-1075, Fax: +82-2-574-1076, E-mail: dohwan2k@naver.com
Received 2026 March 16; Revised 2026 May 9; Accepted 2026 May 14.

Abstract

Objectives

Painful post-traumatic trigeminal neuropathy (PPTTN) is a chronic neuropathic facial pain condition that occurs after trigeminal nerve injury. This study aimed to report the clinical outcomes of Korean medicine treatment including Seungmagalgeun-tang-gamibang and acupuncture in a patient with PPTTN following dental implant surgery.

Methods

This study retrospectively reviewed the medical records of a patient diagnosed with PPTTN who was treated at a Korean medicine clinic. The patient received a Seungmagalgeun-tang-gamibang herbal prescription and acupuncture once weekly during the treatment period. Pain intensity was evaluated using the Numeric Rating Scale (NRS). Clinical progress was assessed through patient interviews, functional observations including eating and lip movement, and changes in pain distribution.

Results

At the initial visit, the patient reported severe pain in the right lower lip and mandibular region with an NRS score of 10. During treatment, pain gradually decreased to NRS 2–3 during the mid-treatment period and improved to NRS 1 at the final follow-up visit. Functional improvements were observed, including increased food intake, improved lip movement, and recovery of daily activities. The pain distribution also progressively decreased from the mandibular region to a small localized area of the lower lip.

Conclusions

This case suggests that Korean medicine treatment including Seungmagalgeun-tang-gamibang and acupuncture may contribute to symptom improvement in patients with PPTTN.

Fig. 1

Changes in numeric rating scale (NRS) scores during treatment

Fig. 2

Changes in pain distribution during treatment

(A) At the initial visit (2024-10-19), the patient reported diffuse neuropathic pain involving the right lower lip and mandibular area (V3 distribution).

(B) During the mid-treatment period (2025-04-05), the pain distribution began to centralize, with a marked reduction in mandibular involvement.

(C) At the final follow-up (2026-01-10), the affected area was significantly minimized to a stable 1 cm focal region on the lower lip.

Prescription of Seungmagalgeun-tang-gamibang (1Day)

Clinical Observation of Functional Changes during Treatment

References

1. Korczeniewska O. A., Kohli D., Benoliel R., Baddireddy S. M., Eliav E.. 2022;Pathophysiology of post-traumatic trigeminal neuropathic pain. Biomolecules 12(12):1753.
2. Kohli D., Katzmann G., Benoliel R., Korczeniewska O. A.. 2021;Diagnosis and management of persistent posttraumatic trigeminal neuropathic pain secondary to implant therapy: A review. J Am Dent Assoc 152(6):483–490.
3. Van der Cruyssen F., Peeters F., De Laat A., Jacobs R., Politis C., Renton T.. 2022;Prognostic factors, symptom evolution, and quality of life of posttraumatic trigeminal neuropathy. Pain 163(4):e557–e571.
4. Van der Cruyssen F., Peeters F., Gill T., De Laat A., Jacobs R., Politis C., et al. 2020;Signs and symptoms, quality of life and psychosocial data in 1331 post-traumatic trigeminal neuropathy patients seen in two tertiary referral centres in two countries. J Oral Rehabil 47(10):1212–1221.
5. Lee J. H., Lee J. M.. 2025;Review of Korean medicine treatments for trigeminal neuralgia in Korean journals. J Korean Med Ophthalmol Otolaryngol Dermatol 38(4):25–44.
6. International Headache Society. 2020. International classification of orofacial pain 1st editionth ed. (ICOP). Cephalagia: 40(2)p. 129–221.
7. International Headache Society. 2018;Classification and diagnostic criteria for headache disorders, 3rd edition. Cephalalgia 38(1):1–211.
8. Keum J. H., Seo Y. S., Kang O. H., Choi J. G., Kwon D. Y.. 2013;Anti-inflammatory effect of Seungmagalgeun-tang extract in human mast cells. Kor J Herbology 28(5):7–11.
9. Nguyen L. T. H., Choi M. J., Shin H. M., Yang I. J.. 2022;Seungmagalgeun-Tang, a traditional herbal formula, alleviates skin inflammation and depression-like behavior in atopic dermatitis mice under sleep deprivation conditions. Hindawi Evidence-Based Complementary and Alternative Medicine 2022:1307173.
10. Chun H. S.. 2024;Clinical research trends on acupuncture treatment for trigeminal neuralgia - Based on PubMed. J Korean Med Ophthalmol Otolaryngol Dermatol 37(2):74–94.
11. Cha H. J., Lee Y. J., Kim H. B., Kim B. S., Sung K. J., Lee Y. R., et al. 2020;Review on clinical studies on Korean medicine treatment for trigeminal neuralgia. Journal of Haehwa Medicine 29(2):12–21.
12. Benoliel R., Kahn J., Eliav E.. 2012;Peripheral painful traumatic trigeminal neuropathies. Oral Diseases 18(4):317–332.

Article information Continued

Fig. 1

Changes in numeric rating scale (NRS) scores during treatment

Fig. 2

Changes in pain distribution during treatment

(A) At the initial visit (2024-10-19), the patient reported diffuse neuropathic pain involving the right lower lip and mandibular area (V3 distribution).

(B) During the mid-treatment period (2025-04-05), the pain distribution began to centralize, with a marked reduction in mandibular involvement.

(C) At the final follow-up (2026-01-10), the affected area was significantly minimized to a stable 1 cm focal region on the lower lip.

Table 1

Prescription of Seungmagalgeun-tang-gamibang (1Day)

Name of Natural Medicine (Herbal Medicine) Weight(g)
龍骨 Fossilia Ossis Mastodi 2.8
鹿茸 Cornu Cervi Parvum 2.8
白芍藥 Paeoniae Radix Alba 2.8
當歸 Angelicae Gigantis Radix 1.87
黃芪 Astragali Radix 1.87
桂枝 Cinnamomi Ramulus 1.87
人蔘 Ginseng Radix Alba 1.87
防風 Saposhnikoviae Radix 1.87
柴胡 Bupleuri Radix 1.4
升麻 Cimicifugae Rhizoma 1.4
牡丹皮 Moutan Cortex 1.4
熟地黃 Rehmanniae Radix Preparata 1.4
白朮 Atractylodis Rhizoma Alba 1.4
陳皮 Citri Unshius Pericarpium 1.4
大棗 Zizyphi Fructus 0.93
甘草 Glycyrrhizae Radix et Rhizoma 0.93
荊芥 Schizonepetae Spica 0.93
香附子 Cyperi Rhizoma 0.93
川芎 Cnidii Rhizoma 0.93
白芷 Angelicae Dahuricae Radix 0.93
Total Amount 32.67

Table 2

Clinical Observation of Functional Changes during Treatment

Date Eating Function Lip Movement/Speech Daily Activity
2024-10-19 Severe discomfort during chewing Difficulty in lip movement Daily activities limited
2024-12-14 Increased food intake Partial improvement Activity level increased
2025-02-08 Soft diet due to discomfort Dysesthesia persisted Activities mostly possible
2025-03-15 Discomfort only during eating Lip movement improved Near-normal daily function
2025-05-10 Normal eating most days Minimal difficulty Increased symptom-free days
2025-11-15 Discomfort only with spicy food Normal speech and movement Normal daily activity
2026-01-10 Normal eating Normal lip movement Fully independent daily life